Cytotoxicity of prion protein-derived cell-penetrating peptides is modulated by pH but independent of amyloid formation

Vineeth Mukundan, Christy Maksoudian, Maria C. Vogel, Ibrahim Chehade, Marios S. Katsiotis, Saeed M. Alhassan, Mazin Magzoub

Research output: Contribution to journalArticle

Abstract

Prion diseases are associated with conversion of cellular prion protein (PrPC) into an abnormally folded and infectious scrapie isoform (PrPSc). We previously showed that peptides derived from the unprocessed N-termini of mouse and bovine prion proteins, mPrP1-28 and bPrP1-30 function as cell-penetrating peptides (CPPs), and destabilize model membrane systems, which could explain the infectivity and toxicity of prion diseases. However, subsequent studies revealed that treatment with mPrP1-28 or bPrP1-30 significantly reduce PrPSc levels in prion-infected cells. To explain these seemingly contradictory results, we correlated the aggregation, membrane perturbation and cytotoxicity of the peptides with their cellular uptake and intracellular localization. Although the peptides have a similar primary sequence, mPrP1-28 is amyloidogenic, whereas bPrP1-30 forms smaller oligomeric or non-fibrillar aggregates. Surprisingly, bPrP1-30 induces much higher cytotoxicity than mPrP1-28, indicating that amyloid formation and toxicity are independent. The toxicity is correlated with prolonged residence at the plasma membrane and membrane perturbation. Both ordered aggregation and toxicity of the peptides are inhibited by low pH. Under non-toxic conditions, the peptides are internalized by lipid-raft dependent macropinocytosis and localize to acidic lysosomal compartments. Our results shed light on the antiprion mechanism of the prion protein-derived CPPs and identify a potential site for PrPSc formation.

Original languageEnglish (US)
Pages (from-to)31-42
Number of pages12
JournalArchives of Biochemistry and Biophysics
Volume613
DOIs
StatePublished - Jan 1 2017

Fingerprint

Cell-Penetrating Peptides
Cytotoxicity
Amyloid
Toxicity
Prions
Peptides
Prion Diseases
Membranes
PrPC Proteins
Agglomeration
Scrapie
Cell membranes
Protein Isoforms
Cell Membrane
Prion Proteins
Lipids

Keywords

  • Aggregation
  • Amyloid
  • Cell-penetrating peptides
  • Cytotoxicity
  • Membrane perturbation
  • Prion protein

ASJC Scopus subject areas

  • Biophysics
  • Biochemistry
  • Molecular Biology

Cite this

Cytotoxicity of prion protein-derived cell-penetrating peptides is modulated by pH but independent of amyloid formation. / Mukundan, Vineeth; Maksoudian, Christy; Vogel, Maria C.; Chehade, Ibrahim; Katsiotis, Marios S.; Alhassan, Saeed M.; Magzoub, Mazin.

In: Archives of Biochemistry and Biophysics, Vol. 613, 01.01.2017, p. 31-42.

Research output: Contribution to journalArticle

Mukundan, Vineeth ; Maksoudian, Christy ; Vogel, Maria C. ; Chehade, Ibrahim ; Katsiotis, Marios S. ; Alhassan, Saeed M. ; Magzoub, Mazin. / Cytotoxicity of prion protein-derived cell-penetrating peptides is modulated by pH but independent of amyloid formation. In: Archives of Biochemistry and Biophysics. 2017 ; Vol. 613. pp. 31-42.
@article{ccf13224ae2d4ccbb6f4cf4cd0220d8b,
title = "Cytotoxicity of prion protein-derived cell-penetrating peptides is modulated by pH but independent of amyloid formation",
abstract = "Prion diseases are associated with conversion of cellular prion protein (PrPC) into an abnormally folded and infectious scrapie isoform (PrPSc). We previously showed that peptides derived from the unprocessed N-termini of mouse and bovine prion proteins, mPrP1-28 and bPrP1-30 function as cell-penetrating peptides (CPPs), and destabilize model membrane systems, which could explain the infectivity and toxicity of prion diseases. However, subsequent studies revealed that treatment with mPrP1-28 or bPrP1-30 significantly reduce PrPSc levels in prion-infected cells. To explain these seemingly contradictory results, we correlated the aggregation, membrane perturbation and cytotoxicity of the peptides with their cellular uptake and intracellular localization. Although the peptides have a similar primary sequence, mPrP1-28 is amyloidogenic, whereas bPrP1-30 forms smaller oligomeric or non-fibrillar aggregates. Surprisingly, bPrP1-30 induces much higher cytotoxicity than mPrP1-28, indicating that amyloid formation and toxicity are independent. The toxicity is correlated with prolonged residence at the plasma membrane and membrane perturbation. Both ordered aggregation and toxicity of the peptides are inhibited by low pH. Under non-toxic conditions, the peptides are internalized by lipid-raft dependent macropinocytosis and localize to acidic lysosomal compartments. Our results shed light on the antiprion mechanism of the prion protein-derived CPPs and identify a potential site for PrPSc formation.",
keywords = "Aggregation, Amyloid, Cell-penetrating peptides, Cytotoxicity, Membrane perturbation, Prion protein",
author = "Vineeth Mukundan and Christy Maksoudian and Vogel, {Maria C.} and Ibrahim Chehade and Katsiotis, {Marios S.} and Alhassan, {Saeed M.} and Mazin Magzoub",
year = "2017",
month = "1",
day = "1",
doi = "10.1016/j.abb.2016.11.001",
language = "English (US)",
volume = "613",
pages = "31--42",
journal = "Archives of Biochemistry and Biophysics",
issn = "0003-9861",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Cytotoxicity of prion protein-derived cell-penetrating peptides is modulated by pH but independent of amyloid formation

AU - Mukundan, Vineeth

AU - Maksoudian, Christy

AU - Vogel, Maria C.

AU - Chehade, Ibrahim

AU - Katsiotis, Marios S.

AU - Alhassan, Saeed M.

AU - Magzoub, Mazin

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Prion diseases are associated with conversion of cellular prion protein (PrPC) into an abnormally folded and infectious scrapie isoform (PrPSc). We previously showed that peptides derived from the unprocessed N-termini of mouse and bovine prion proteins, mPrP1-28 and bPrP1-30 function as cell-penetrating peptides (CPPs), and destabilize model membrane systems, which could explain the infectivity and toxicity of prion diseases. However, subsequent studies revealed that treatment with mPrP1-28 or bPrP1-30 significantly reduce PrPSc levels in prion-infected cells. To explain these seemingly contradictory results, we correlated the aggregation, membrane perturbation and cytotoxicity of the peptides with their cellular uptake and intracellular localization. Although the peptides have a similar primary sequence, mPrP1-28 is amyloidogenic, whereas bPrP1-30 forms smaller oligomeric or non-fibrillar aggregates. Surprisingly, bPrP1-30 induces much higher cytotoxicity than mPrP1-28, indicating that amyloid formation and toxicity are independent. The toxicity is correlated with prolonged residence at the plasma membrane and membrane perturbation. Both ordered aggregation and toxicity of the peptides are inhibited by low pH. Under non-toxic conditions, the peptides are internalized by lipid-raft dependent macropinocytosis and localize to acidic lysosomal compartments. Our results shed light on the antiprion mechanism of the prion protein-derived CPPs and identify a potential site for PrPSc formation.

AB - Prion diseases are associated with conversion of cellular prion protein (PrPC) into an abnormally folded and infectious scrapie isoform (PrPSc). We previously showed that peptides derived from the unprocessed N-termini of mouse and bovine prion proteins, mPrP1-28 and bPrP1-30 function as cell-penetrating peptides (CPPs), and destabilize model membrane systems, which could explain the infectivity and toxicity of prion diseases. However, subsequent studies revealed that treatment with mPrP1-28 or bPrP1-30 significantly reduce PrPSc levels in prion-infected cells. To explain these seemingly contradictory results, we correlated the aggregation, membrane perturbation and cytotoxicity of the peptides with their cellular uptake and intracellular localization. Although the peptides have a similar primary sequence, mPrP1-28 is amyloidogenic, whereas bPrP1-30 forms smaller oligomeric or non-fibrillar aggregates. Surprisingly, bPrP1-30 induces much higher cytotoxicity than mPrP1-28, indicating that amyloid formation and toxicity are independent. The toxicity is correlated with prolonged residence at the plasma membrane and membrane perturbation. Both ordered aggregation and toxicity of the peptides are inhibited by low pH. Under non-toxic conditions, the peptides are internalized by lipid-raft dependent macropinocytosis and localize to acidic lysosomal compartments. Our results shed light on the antiprion mechanism of the prion protein-derived CPPs and identify a potential site for PrPSc formation.

KW - Aggregation

KW - Amyloid

KW - Cell-penetrating peptides

KW - Cytotoxicity

KW - Membrane perturbation

KW - Prion protein

UR - http://www.scopus.com/inward/record.url?scp=84994853820&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84994853820&partnerID=8YFLogxK

U2 - 10.1016/j.abb.2016.11.001

DO - 10.1016/j.abb.2016.11.001

M3 - Article

VL - 613

SP - 31

EP - 42

JO - Archives of Biochemistry and Biophysics

JF - Archives of Biochemistry and Biophysics

SN - 0003-9861

ER -